Personal information

Hereditary ca, breast, ovarian & testicular ca, myotonic dystrophy, psychosocial/behavioral, 2nd ca

Biography

Dr. Greene received a B.A. (English) from Yale College, an M.D. from Tufts University, and completed his training in Internal Medicine at the Massachusetts General Hospital in Boston. He spent three years with the Epidemic Intelligence Service of the U.S. Centers for Disease Control and Prevention, and then came to the National Cancer Institute in 1975 as a Staff Fellow in the Environmental Epidemiology Branch. Dr. Greene completed his medical oncology fellowship at the Medicine Branch, NCI, and is board-certified in both Internal Medicine and Medical Oncology. In 1977, he became a Senior Investigator and, subsequently, Coordinator of Family Studies within the Environmental Epidemiology Branch (EEB). In 1984, Dr. Greene was appointed Deputy Branch Chief of EEB. In 1985, he left government service to enter the private practice of medical oncology and hematology in Sun City, Arizona. In 1991, he joined the faculty of Mayo Clinic Scottsdale as a Professor of Oncology in the Mayo Medical School. While at Mayo, he was a participating investigator with a variety of cooperative oncology groups, including NCCTG, ECOG and NSABP. Dr. Greene became the Principal Investigator for the Mayo Cancer Center’s Familial Cancer Program in 1994. In the fall of 1999, he returned to NCI as the Branch Chief of the newly-created Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics. Dr. Greene served as Branch Chief through 2013. He continued to direct clinical research studies as a Senior Principal Investigator within the branch. He has published 333 peer-reviewed scientific articles, 8 editorial/commentaries and 24 book chapters. His major research interests included familial/hereditary cancers, genetic determinants of outcomes following cancer treatment, as well as intervention studies (cancer screening, surgical risk reduction and chemoprevention) in genetically at-risk populations, genetic modifiers of cancer risk, psychosocial and behavioral aspects of familial cancer, and leveraging alert clinical observations into novel etiologic insights. He served as the National Study Chair and Principal Investigator for GOG Protocol 0199, the National Ovarian Cancer Prevention and Early Detection Study. He retired from NCI in 2019, since which time he has served as an NIH Emeritus Investigator with the Clinical Genetics Branch, NCI.

Activities

Employment (1)

National Cancer Institute: Bethesda, MD, US

1999-07-01 to 2019-12-31 | NIH Emeritus Investigator (Division of Cancer Epidemiology & Genetics, Clinical Genetics Branch)
Employment
Source: Self-asserted source
Mark H. Greene, M.D.

Education and qualifications (2)

Tufts University School of Medicine: Boston, MA, US

1966-09-01 to 1970-06-30 | M.D. (Medical School)
Education
Source: Self-asserted source
Mark H. Greene, M.D.

Yale University: New Haven, CT, US

1962-09-01 to 1966-06-30 | BA (English)
Education
Source: Self-asserted source
Mark H. Greene, M.D.